- Hypophosphatasia mild
- Rathburn disease
News & Events
On this page
ORDR Co-Sponsored Conferences
2016 Rare Disease Day at NIH, Monday, February 29, 2016
Location: Building 10, Masur Auditorium, National Institutes of Health, Bethesda, MD
Description: The 2016 Rare Disease Day at NIH will take place on February 29. The event, sponsored by NCATS and the NIH Clinical Center, aims to raise awareness about rare diseases, the patients they affect and the research collaborations that are addressing rare disease challenges. The day will feature tours, posters and exhibits, and presentations.
Advances in Mineral Metabolism (AIMM) 2015 Annual Meeting, Monday, April 06, 2015 - Friday, April 10, 2015
Location: Stonebridge Inn, Snowmass Village, CO
Description: The objective of the Advances in Mineral Metabolism conferences is to bring together scientists and clinicians whose research interests include skeletal development, bone and cartilage cell biology, molecular genetics of the skeleton and other musculoskeletal tissues, and physiology of bone and other connective tissues in a unique and engaging format that promotes open discussion and exchange of ideas. AIMM conference attendees will include senior scientists and young independent investigators, and post-doctoral trainees from both the academic and industrial sectors who will present their research results and discuss a broad array of topics of current interest in bone and musculoskeletal biology.
Mechanistic and Therapeutic Insights into Skeletal Biology Learned from the Study of Rare Bone Diseases, Thursday, September 11, 2014
Location: Hilton Americas, Houston, TX
Description: <p>This workshop, coordinated by the National Bone Health Alliance (NBHA) in partnership with the Rare Bone Disease Patient Network and with the support of the American Society for Bone and Mineral Research (ASBMR) and the United States Bone and Joint Initiative (USBJI) aims to: 1)Convene a multi-disciplinary group of experts including researchers, clinicians, and patients with rare bone diseases to advance our understanding of skeletal biology and encourage the development of novel therapies to improve outcomes for individuals with both common and rare bone diseases;<span> </span>2)Identify gaps in our knowledge regarding the biologic mechanisms underlying rare bone disorders and share effective research strategies in translational and therapeutic areas;<span> </span>3)Encourage broad participation both by holding the event the day before the ASBMR 2014 Annual Meeting and providing funding for a significant number of young investigators to attend; and 4)Disseminate the results broadly by publishing the proceedings of the program in a peer-reviewed journal.</p>